<DOC>
	<DOCNO>NCT02084563</DOCNO>
	<brief_summary>The objective study describe prevalence prognostic impact common genetic abnormality patient Myeloid Neoplasms , include Acute Myeloid Leukemia ( AML ) , Myeloproliferative Neoplasms ( MPN ) , Myelodysplastic Syndromes ( MDS ) Myeloproliferative/Myelodysplastic Neoplasms . Patients sample blood and/or bone marrow collect sent Hospital Israelita Albert Einstein analysis storage . Patients diagnosis Acute Myeloid Leukemia treat accord uniform protocol .</brief_summary>
	<brief_title>Study Molecular Genetic Abnormalities Patients With Myeloid Neoplasms</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Myeloproliferative Disorders</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Decitabine</mesh_term>
	<mesh_term>Azacitidine</mesh_term>
	<mesh_term>Daunorubicin</mesh_term>
	<criteria>Acute Myeloid LeukemiaIntensive Chemotherapy Diagnosis AML accord WHO criteria Age great 18 year Performance status ( ECOG ) 02 Adequate liver kidney function Signed Informed Consent form No prior therapy AML , except use hydroxyurea control elevate white blood cell count Adequate contraception fertile men woman Eligible intensive chemotherapy ( judged treat physician ) Acute myeloid leukemia retinoic acid receptor alpha ( RARA ) translocation ( APL , acute promyelocytic leukemia ) Pregnant woman HIVpositivity New York Heart Association class III IV congestive heart failure Patient refuse use adequate contraception History hypersensibility use chemotherapy drug Patient refuse sign informed consent form Acute Myeloid LeukemiaNonIntensive Chemotherapy Diagnosis AML accord WHO criteria Age great 18 year Signed Informed Consent form No prior therapy AML , except use hydroxyurea control elevate white blood cell count Adequate contraception fertile men woman Noneligible intensive chemotherapy ( judged treat physician ) Acute myeloid leukemia RARA translocation ( APL , acute promyelocytic leukemia ) Pregnant woman HIVpositivity Patient refuse use adequate contraception History hypersensibility use chemotherapy drug Patient refuse sign informed consent form Chronic Myeloid Disorders : Diagnosis Myeloproliferative Neoplasm Myelodysplastic Syndrome Myeloproliferative/Myelodysplastic Neoplasm accord WHO criteria Age great 18 year Signed Informed Consent form Patient refuse sign informed consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Acute Myeloid Leukemia</keyword>
	<keyword>Myeloproliferative Neoplasms</keyword>
	<keyword>Myelodysplastic Syndromes</keyword>
	<keyword>Myeloproliferative/Myelodysplastic Neoplasm</keyword>
	<keyword>Leukemia</keyword>
	<keyword>MDS</keyword>
	<keyword>MPN</keyword>
	<keyword>AML</keyword>
	<keyword>Chronic myelomonocytic leukemia ( CMML )</keyword>
	<keyword>Polycythemia Vera ( PV )</keyword>
	<keyword>Essential Thrombocythemia ( ET )</keyword>
	<keyword>Myelofibrosis ( MF )</keyword>
</DOC>